Skip to main navigation
  • Contact Us twitter linkedin
  • Homepage
  • About Us
    • Senior Leadership Team
    • Board of Directors
    • Scientific Advisory Board
  • Our Approach
    • GPS Platform
    • Publications & Presentations
  • Our Pipeline
    • XTX101 (anti-CTLA-4)
    • XTX202 (IL-2)
    • XTX301 (IL-12)
    • Expanded Access Policy
  • Investors & Media
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials & Filings
      • SEC Filings
      • Annual Reports
    • Corporate Governance
      • Documents & Charters
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Stock Information
      • Analyst Coverage
    • Investor FAQs
    • Email Alerts
    • Contact
  • Careers

News Releases

February 16, 2023
Xilio Therapeutics to Present at the Citi 2023 Virtual Oncology Leadership Summit
Read More
February 2, 2023
Xilio Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day
Read More

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
Displaying 11 - 12 of 12
Xilio Therapeutics, Inc logo

Xilio Therapeutics
828 Winter Street, Waltham, MA 02451

© 2023 Xilio Therapeutics, Inc.
All Rights Reserved

Privacy Policy

We use cookies to help personalize your experience. For more information on how we use cookies and similar technologies, and how you can change your settings, please see our Privacy Policy.
Cookie SettingsOk